Lung Cancer Clinical Trial
Comparison of Imaging Characteristics of uEXPLORER and Conventional PET/CT in Patients With Lung Cancer, Lymphoma, and Melanoma
Summary
To determine the minimum scan duration for fluorine-18 positron-emitting radioactive isotope-fluorodeoxyglucose (18F-FDG) positron emission tomography (PET)/computed tomography (CT) scans performed on a total-body PET/CT scanner that results in non-inferior image quality to 18F-FDG PET/CT scans performed on a conventional PET/CT scanner. The subject population will be patients being staged for lung cancer, lymphoma, or melanoma.
Eligibility Criteria
Inclusion Criteria:
Ability to understand and willingness to sign an informed consent form.
Ability to adhere to the study visit schedule and all protocol requirements.
Men and women ≥18 years of age.
Diagnosis or suspected diagnosis of lung cancer, melanoma or lymphoma.
Patients who have been referred for a PET/CT scan.
Exclusion Criteria:
Pregnant women.
Claustrophobia.
Any significant medical condition that in the opinion of the investigator would prevent the subject from participating and/or adhering to study related procedures or interfere with subject safety.
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There is 1 Location for this study
Sacramento California, 95817, United States
How clear is this clinincal trial information?